Charles River Laboratories CRL RMS — Total Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's rms — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's RMS — total revenue?
- Charles River Laboratories (CRL) reported RMS — total revenue of $208.37M in Q1 2026.
- How has Charles River Laboratories's RMS — total revenue changed year-over-year?
- Charles River Laboratories's RMS — total revenue decreased by 2.2% year-over-year, from $213.07M to $208.37M.
- What is the long-term trend for Charles River Laboratories's RMS — total revenue?
- Over 2 years (2023 to 2025), Charles River Laboratories's RMS — total revenue has grown at a 3.3% compound annual growth rate (CAGR), from $792.34M to $846.08M.
- What does RMS — total revenue mean?
- The total sales generated by the Research Models and Services business segment.
- How do you interpret RMS — total revenue?
- An increase indicates growing demand for research models and related scientific services, while a decrease may signal market saturation or reduced R&D spending by clients.
- How does RMS — total revenue compare across companies?
- Comparable to revenue metrics for life sciences supply or contract research organization (CRO) segments.